Frank Manganella

Corporate Officer/Principal bei NEXIEN BIOPHARMA, INC.

58 Jahre

Health Technology

Finance

Consumer Services

Aktive Positionen von Frank Manganella

Unternehmen	Position	Beginn	Ende
NEXIEN BIOPHARMA, INC.	Corporate Officer/Principal	30.10.2018	-
CH3 Partners LLC	Vorstandsvorsitzender	01.10.2015	-
CH3 Partners LLC	Gründer	01.10.2015	-
CRx Bio Holdings LLC CRx Bio Holdings LLC Pharmaceuticals: OtherHealth Technology CRx Bio Holdings LLC engages in the research and development of advanced cannabinoid therapeutic formulations with the objective of enhancing the bioavailability, pharmacokinetics, and pharmacodynamics of cannabinoids. The company was founded by Alex Wasyl and is headquartered in Princeton, NJ.	Finanzdirektor/CFO	01.11.2017	-
Ch3 Ventures	Gründer	-	-
Ch3 Ventures	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
COMMERZBANK AG	Corporate Officer/Principal	01.03.2011	01.06.2014

Durham University Business School

Masters Business Admin

International

Operativ

Corporate Officer/Principal	3
Founder	2
Chief Executive Officer	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
COMMERZBANK AG	Finance
NEXIEN BIOPHARMA, INC.	Health Technology

Private Unternehmen	3
CRx Bio Holdings LLC CRx Bio Holdings LLC Pharmaceuticals: OtherHealth Technology CRx Bio Holdings LLC engages in the research and development of advanced cannabinoid therapeutic formulations with the objective of enhancing the bioavailability, pharmacokinetics, and pharmacodynamics of cannabinoids. The company was founded by Alex Wasyl and is headquartered in Princeton, NJ.	Health Technology
CH3 Partners LLC
Ch3 Ventures